US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Aptus Drawdown Managed Equity ETF

56.18

+0.04500.08%

Volume:863

Turnover:48.49K

Market Cap:305.69M

PE:- -

High:56.23

Open:56.23

Low:56.18

Close:56.13

52wk High:57.35

52wk Low:48.24

Shares:5.44M

Float Shares:5.44M

Volume Ratio:0.24

T/O Rate:0.02%

Dividend:0.20

Dividend Rate:0.35%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Press Release: Anavex Life Sciences Reports Preliminary Second Quarter 2026 Financial Results and Provides Business Update

ADM Energy gains adjournment in HMRC winding-up case as tax claim is cut

Hedge Fund Manager Ackman Sees Meta and Amazon as Undervalued, Claims Broader Market Not Overpriced

ADM Energy Faces HMRC Winding-Up Petition as It Scrambles for Funding

AstraZeneca’s AZD1390 ADME Study Lays Groundwork for Future Oncology Upside

InnoCare Announce First Subject Dosed in Phase 1 Clinical Trial of ICP-054, a Novel Potentially Best-in-Class Oral IL-17AA/AF Inhibitor

Erasca Announces Positive Preliminary Phase 1 Dose Escalation Data for Potentially Best-in-Class Pan-RAS Molecular Glue ERAS-0015 in KRAS-Mutant Solid Tumors

Erasca to Host Conference Call and Webcast to Discuss Preliminary Phase 1 Dose Escalation Data for Potentially Best-in-Class Pan-RAS Molecular Glue ERAS-0015

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/ADME/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ADME","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADME\",,,,,undefined,":{"symbol":"ADME","market":"US","secType":"STK","nameCN":"Aptus Drawdown Managed Equity ETF","latestPrice":56.175,"timestamp":1787671019852,"preClose":56.13,"halted":0,"volume":863,"delay":0,"changeRate":0.0008017103153392945,"floatShares":5441752,"shares":5441752,"eps":0,"marketStatus":"Trading","change":0.045,"latestTime":"08-25 11:24:48 EDT","open":56.23,"high":56.23,"low":56.175,"amount":48494.371729,"amplitude":0.00098,"askPrice":56.25,"askSize":100,"bidPrice":56.15,"bidSize":600,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787688000000},"marketStatusCode":2,"adr":0,"exchange":"CBOE","adjPreClose":56.13,"sharesOutstanding":4691755,"nav":56.26,"aum":306153136.3,"dividendRate":0.003498,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":56.13,"preClose":56.13,"latestTime":"16:15 EDT","volume":10,"amount":561.3,"timestamp":1787602500160,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.240362},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADME\",,,,,undefined,":{"symbol":"ADME","floatShares":5441752,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.240362,"shares":5441752,"dividePrice":0.1965,"high":56.23,"amplitude":0.00098,"preClose":56.13,"low":56.175,"week52Low":48.24,"pbRate":"--","week52High":57.35,"institutionHeld":0,"latestPrice":56.175,"committee":0.714286,"eps":0,"divideRate":0.003498,"volume":863,"delay":0,"ttmEps":0,"open":56.23,"prevYearClose":51.31,"prevWeekClose":56.2798,"prevMonthClose":55.17,"prevQuarterClose":55.646,"fiveDayClose":56.45,"twentyDayClose":54.841,"sixtyDayClose":56.3593},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ADME\",params:#limit:5,,,undefined,":[{"date":"2026-06-29","symbol":"ADME","amount":0.05302762,"announcedDate":"2026-06-26","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-29","defaultRemindTime":1782739800000,"name":"Aptus Drawdown Managed Equity ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-29","currency":"USD","dateTimestamp":1782705600000,"payDate":"2026-06-30"},{"date":"2026-03-30","symbol":"ADME","amount":0.07172087,"announcedDate":"2026-03-27","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-30","defaultRemindTime":1774877400000,"name":"Aptus Drawdown Managed Equity ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-30","currency":"USD","dateTimestamp":1774843200000,"payDate":"2026-03-31"},{"date":"2025-12-30","symbol":"ADME","amount":0.03653443,"announcedDate":"2025-12-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-30","defaultRemindTime":1767105000000,"name":"Aptus Drawdown Managed Equity ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-30","currency":"USD","dateTimestamp":1767070800000,"payDate":"2025-12-31"},{"date":"2025-09-29","symbol":"ADME","amount":0.03544252,"announcedDate":"2025-09-26","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-29","defaultRemindTime":1759152600000,"name":"Aptus Drawdown Managed Equity ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-29","currency":"USD","dateTimestamp":1759118400000,"payDate":"2025-09-30"},{"date":"2025-06-27","symbol":"ADME","amount":0.06624,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-27","defaultRemindTime":1751031000000,"name":"Aptus Drawdown Managed Equity ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-30","payableDate":"2025-06-27","currency":"USD","dateTimestamp":1750996800000,"payDate":"2025-06-30"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ADME\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-28","recordDate":"2016-12-30","paymentDate":"2017-01-03","value":0.178221,"currency":"USD"},{"executeDate":"2018-12-28","recordDate":"2018-12-31","paymentDate":"2019-01-02","value":0.242457,"currency":"USD"},{"executeDate":"2019-12-24","recordDate":"2019-12-26","paymentDate":"2019-12-27","value":0.21310878,"currency":"USD"},{"executeDate":"2020-03-17","recordDate":"2020-03-18","paymentDate":"2020-03-19","value":0.0487927,"currency":"USD"},{"executeDate":"2020-06-16","recordDate":"2020-06-17","paymentDate":"2020-06-18","value":0.0366754,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ADME\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ADME\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2655872868","title":"Press Release: Anavex Life Sciences Reports Preliminary Second Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2655872868","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655872868?lang=en_us&edition=fundamental","pubTime":"2026-07-30 20:00","pubTimestamp":1785412800,"startTime":"0","endTime":"0","summary":"greatest potential for success. The strategy concentrates resources on. blarcamesine across three CNS indications: early Alzheimer's disease and. Rett syndrome, where the Company's clinical and regulatory foundation is. most advanced, and Fragile X, where FDA Orphan Drug Designation,supportive preclinical and biomarker data, and the absence of any. approved therapy may lead to a promising regulatory path with the FDA.Alzheimer's Disease Program-- At the end of March 2026, the Company opened an Investigational New Drug.  application for early Alzheimer's disease with the FDA. This is an. important milestone: the IND enables clinical studies to be conducted in. the U.S. and provides the basis for substantive discussions with the FDA. to align on the Company's future clinical development for early. -- Two foundational clinical pharmacology studies are proceeding","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4135","BK4081","BK4097","BK4585","BK4085","BK4022","R","BK4087","EMA","LU1878469433.USD","BK4110","DDI","BK4139","SOCL","ADME","BK4588","IND","CHMP","CNS","LABU","RPD","AAIC","AVXL","BK4232"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653711235","title":"ADM Energy gains adjournment in HMRC winding-up case as tax claim is cut","url":"https://stock-news.laohu8.com/highlight/detail?id=2653711235","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653711235?lang=en_us&edition=fundamental","pubTime":"2026-07-23 14:20","pubTimestamp":1784787654,"startTime":"0","endTime":"0","summary":"An update from ADM Energy plc ( ($GB:ADME) ) is now available. ADM Energy has built a diversified upstream-focused portfolio, combining U.S. onshor...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/adm-energy-gains-adjournment-in-hmrc-winding-up-case-as-tax-claim-is-cut?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/adm-energy-gains-adjournment-in-hmrc-winding-up-case-as-tax-claim-is-cut?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2211817866.USD","PBJ","BK4189","LU1571399168.USD","BK4597","FTXG","BK4585","BK4588","VEGI","ADME","LU0471298777.SGD","ADM","LU0385154629.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148056319","title":"Hedge Fund Manager Ackman Sees Meta and Amazon as Undervalued, Claims Broader Market Not Overpriced","url":"https://stock-news.laohu8.com/highlight/detail?id=1148056319","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148056319?lang=en_us&edition=fundamental","pubTime":"2026-07-21 16:06","pubTimestamp":1784621162,"startTime":"0","endTime":"0","summary":"Prominent hedge fund manager Bill Ackman has recently disclosed he is making significant bets on tech giants Meta and Amazon.com Inc (NASDAQ: AMZN), describing both as high-quality investments with...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BYQQ9H92.USD","ZNOV","SG9999015978.USD","AMZW","SPXL","LU1935043536.SGD","LU2357305700.SGD","AIOO","LU2275660780.HKD","BK4551","LU0786609619.USD","IE00BJJMRX11.SGD","LU1201861249.SGD","LU2242649171.HKD","BK4548","LU0157215616.USD","JULQ","LU0267386448.USD","LU2552382215.SGD","LU2265009873.SGD","XSPI","SPYM","LU0203202063.USD","LU0965508806.USD","SG9999018857.SGD","LU1935042215.USD","LU0082616367.USD","LU1674673428.USD","SGXZ51526630.SGD","IE0009356076.USD","LU2471134879.HKD","DSPY","LU0345770308.USD","LU2092627202.USD","BK4604","LU2125154778.USD","LU0345770993.USD","IE00B7SZLL34.SGD","LU1934455863.HKD","LU1267930573.SGD","LU1366333091.USD","LU1861127337.USD","LU2237957811.SGD","SG9999014898.SGD","IE00BKVL7J92.USD","IE000WAW04H5.SGD","IE00B1BXHZ80.USD","LU2111349929.HKD","HIBL","SPXU","LU0320765489.SGD","LU1861559042.SGD","LU0742534661.SGD","GB00BDT5M118.USD","LU1720051108.HKD","AZYY","LU0348723411.USD","SG9999000418.SGD","LU0957791311.USD","BK4581","LU0096362180.USD","LU0314104364.USD","LU0070217475.USD","LU0784384876.USD","LU2023250330.USD","LU2271345857.HKD","LU2461242641.AUD","LU0061474705.USD","BFLB","LU0345768740.USD","LU0320765059.SGD","LU0820561909.HKD","YMAG","LU0417517546.SGD","LU0820561818.USD","OGIG","LU0061475181.USD","LU0871640123.AUD","LU2471134796.USD","LU2360032135.SGD","AAPL","LU1803068979.SGD","SMAX","LU0210533765.USD","LU0353189680.USD","LU0642271901.SGD","ONLN","LU1201861165.SGD","LU0310800379.SGD","LU0310799852.SGD","LU0466842654.USD","LU2430703095.HKD","BK4533","IE00BMPRXN33.USD","LU2211815571.USD","LU2361045086.USD","BK4585","LU0308772762.SGD","LU2381873111.SGD","LU1116320901.HKD","LU2213496289.HKD","LU0251132253.USD","IE00B4JS1V06.HKD","LU0174119429.USD","LU1935043023.USD","LU0390134368.USD","LU2602419157.SGD","AJUL","BK4598","LU1232071149.USD","SPBU","LU0070302665.USD","BDVL","LU0128525929.USD","IE000F7OJYX1.SGD","SG9999001077.SGD","IE0000B7K699.USD","MSFT","LU1935042488.USD","LU2065171311.SGD","LU2168564149.EUR","SPYU","LU0109391861.USD","SG9999004303.SGD","LU1778281490.HKD","OCTJ","LU2054465674.USD","BK4535","IE00BQXX3C00.GBP","LU2756315318.SGD","LU0149725797.USD","IE0004086264.USD","LU1720051017.SGD","LU0096364046.USD","LU0708994859.HKD","HK0000532082.HKD","LU2237438978.USD","ALDB","HK0000914686.HKD","LU1244550221.USD","LU0256863902.USD","LU0342679015.USD","LU1880398554.USD","LU2417539215.USD","LU0784383803.USD","LU2720916845.USD","LU0882574139.USD","LU2360106780.USD","LU2999663052.SGD","LU0143551892.USD","MMAX","IVV","LU1244550577.SGD","LU1934455277.USD","LU0133085943.USD","LU1316542783.SGD","LU0265550359.USD","LU1880398471.USD","BK4588","LU0964807845.USD","IE0002270589.USD","BK4532","IE00BJLML261.HKD","LU1116320737.USD","DWEQ","LU2750360997.AUD","AMZY","IE00B4YYXB79.USD","SG9999014880.SGD","CLIX","LU1804176565.USD","LU2236285917.USD","PMMY","RTH","LU0138981039.USD","UJUN","SEPP","SGXZ81514606.USD","LU2362541273.HKD","IE00BWXC8680.SGD","LU0787776722.HKD","LU2420271590.USD","IE0001KFT4U8.USD","SEPI","LU1267930490.SGD","CPSY","LU2637965513.SGD","LU0097036916.USD","ABUF","LU0345768153.USD","LU0048573561.USD","LU0211328371.USD","LU2362541513.USD","SPY","IE00BKDWB100.SGD","LU0889565833.HKD","LU1046421795.USD","LU2108987350.USD","LU1989764664.SGD","SPYH","IE00B19Z9505.USD","LU1989764748.USD","SGXZ23171101.USD","IE00BKPKM429.USD","LU2317271919.USD","IE000SO60NU8.SGD","LU0251142724.SGD","DDFA","IE000MB6IJN5.SGD","NOVP","LU1261432733.SGD","IE000YTNTUN2.SGD","LU0072462426.USD","LU0861579265.USD","LU0312595415.SGD","LU2023250843.SGD","SSO","LU1244550494.USD","LU1069344957.HKD","DDFL","LU2087621335.USD","SH","LU1917777945.USD","LU1934455194.USD","IE00BZ1G4Q59.USD","LU0170899867.USD","LU0289960550.SGD","AMZN","PVEX","LU0198837287.USD","LU0823434740.USD","LU2430703178.SGD","LU2746668461.USD","LU0175139822.USD","SG9999014914.USD","MAGY","IE00BQXX3D17.EUR","LU1868837300.USD","LU1914381329.SGD","AMZZ","LU0302445910.USD","LU2247934214.USD","LU1868836914.USD","LU0210528500.USD","LU0029864427.USD","IE0004445015.USD","LU0823411888.USD","IE00BJJMRY28.SGD","IE00BFXG0V08.USD","LU0080751232.USD","LU2403377893.USD","LU1429558221.USD","IE00B1XK9C88.USD","LU0788109477.HKD","BK4534","IE00BMPRXR70.SGD","LU1435385759.SGD","LU0345774391.USD","ZMAR","LU2023251221.USD","LU0265550946.USD","SG9999002232.USD","INFO","LU1267930730.SGD","LU0724617625.USD","IE000W1ABFV2.USD","IE000KEQY171.SGD","LU1037948541.HKD","JUNM","LU0689472784.USD","ADME","LU2452424414.USD","STOX","LU2089283258.USD","LU0345769128.USD","LU0708995401.HKD","LU0061474960.USD","LU0210536198.USD","LU0053666078.USD","IE00B5TLWC47.USD","LU1037948897.HKD","LU0784385840.USD","BFLX","SWAN","LU2361044949.HKD","LU2756315664.SGD","LU0154236417.USD","WANT","AMZD","LU2456880835.USD","LU1988902786.USD","SG9999018865.SGD","LU0158827781.USD","BK4507","LU0456855351.SGD","LU2543165471.USD","LU1718418525.SGD","LU1814569148.SGD","BK4527","LU2028103732.USD","NVDA","LU0648000940.SGD","LU2063271972.USD","LU2065171402.SGD","LU0077335932.USD","AMZU","IE00BFSS7M15.SGD","LU1066051225.USD","LU2462157665.USD","LU2462591350.SGD","LCR","SOCL","BK4554","YSPY","WTAI","LU0234570918.USD","BK4538","LU1301847155.USD","LU0234572021.USD","LU1127390331.HKD","BK4503","LU2106854487.HKD","LU2463028550.USD","LU1074936037.SGD","LU0011850046.USD","LU1839511570.USD","GFEB","IE00BQXX3F31.USD","LU2860962120.EUR","LU0251131958.USD","LU1823568750.SGD","LU2264538146.SGD","LU2764263039.SGD","LU0949170426.SGD","LU2168564222.USD","LU2430703251.USD","BK4561","LU0528227936.USD","LU2552382058.USD","LU2471134952.CNY","LU2250418816.HKD","LU2087625088.SGD","LU1852331112.SGD","BK4612","LU1496350171.SGD","LU1868837136.USD","IE0034235303.USD","FMCX","LU0719512351.SGD","LU0683600562.USD","LU1974910355.USD","LU0130102774.USD","LU1633808545.USD","LU1119994496.HKD","LU0289941410.SGD","LU0823434583.USD","LU1235294995.USD","LU1323610961.USD","LU0354030511.USD","LU0354030438.USD","LU0162691827.USD","LU2592432038.USD","SHDG","LU1066053197.SGD","BK4566","LU2211817866.USD","LU0345774631.USD","LU1153585028.USD","LU0276348264.USD","IE00BK4W5M84.HKD","LU0256863811.USD","IE0005OL40V9.USD","LU2168564065.EUR","LU0965509283.SGD","LU1064131342.USD","LU2168564495.EUR","LU1691799644.USD","IE0009G5SDU7.USD","IE00B19Z3B42.SGD","LU2237957902.USD","IE00BJTD4V19.USD","LU1551013342.USD","BK4579","LU1551013425.SGD","UPRO","TRND","IE00BN29S564.USD","LU0980610538.SGD","LU2896262040.SGD","CPST","HK0000304797.USD","LU1496350502.SGD","LU0672654240.SGD","LU2077746001.SGD","SPUU","IE0003U64NQ7.SGD","LU0203201768.USD","LU0345769631.USD","LU1548497426.USD","LU0965509101.SGD","UOCT","GOOG","IE00BFSS8Q28.SGD","ILDR","LU0208291251.USD","RSDE","LU1366192091.USD","LU2746668974.SGD","XBFR","LU0353189763.USD","IE000BZT7R73.USD","LU0823421333.USD","BK4123","LU1815333072.USD","HK0000914660.USD","BK4550","LU2552382132.HKD","LU1791710400.SGD","VERS","BK4122","VOO","EQTY","IE00B19Z8X17.USD","IE00BK4W5L77.USD","LU0079474960.USD","SPXS","USAW.SI","LU2125154935.USD","IE00B775H168.HKD","LU0215105999.USD","LU2065170008.USD","LU2462591277.SGD","LU1868836757.USD","LU0820562030.AUD","BK4559","SGXZ31699556.SGD","LU0072461881.USD","LU0158827948.USD","SG9999015945.SGD","BK4543","HK0000304805.HKD","BK4524","LU0494093205.USD","HULL","LU2168563687.JPY","LU1935042991.SGD","IE00B3S45H60.SGD","LU1145028129.USD","CAIE","IE00B19Z8W00.USD","SDS","LU1629891620.HKD","LU1280957306.USD","SG9999017495.SGD","BUFP","LU1084165304.USD","DMAX","LU0648001328.SGD","LU0323591593.USD","SPYQ","LU2242650005.HKD","LU1674673691.USD","LU0784385170.HKD","LU2505996681.GBP","LU1791710582.SGD","LU2764263203.CNY","LU0965509010.AUD","LU0238689110.USD","LU2092937148.SGD","LU1035775433.USD","LU2326559502.SGD","BK4592","LU0127658192.USD","LU0943347566.SGD","MSTB","IE00B7KXQ091.USD","LU0316494557.USD","LU0109392836.USD","BLUC","IE00B775SV38.USD","AAUM","LU2505996509.AUD","VSL","IE00BJTD4N35.SGD","LU1066051498.USD","IE000ITXATA3.USD","LU0048584097.USD","TAPR","LU2764262908.HKD","BK4220","LU2023250504.SGD","LU2083900584.USD","IE00B19Z3581.USD","LU2089284900.SGD","LU2954938101.SGD","SG9999015986.USD","LU1883839398.USD","SPDN","LU0823421416.USD","LU0107464264.USD","SG9999002224.SGD","META","IE00BMPRXQ63.HKD","LU2362540622.SGD","IE00B5949003.HKD","LU1066051811.HKD","LU0211327993.USD","LU0640476718.USD","IE0004445239.USD","SG9999015952.SGD","IE00B3SWFQ91.USD","LU2750360641.GBP","RSSE","LU2471134523.USD","LU1868836591.USD","SG9999014906.USD","LU0985320562.USD","LU1861558580.USD","LU2361044865.SGD","IE0004091025.USD","LU0056508442.USD","LU2065169927.USD","SGXZ99366536.SGD","BULZ","AMZP","PBNV","BK4596","TSLA","LU2097829019.USD","LU0130103400.USD","TJAN","LU2487616109.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651746886","title":"ADM Energy Faces HMRC Winding-Up Petition as It Scrambles for Funding","url":"https://stock-news.laohu8.com/highlight/detail?id=2651746886","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651746886?lang=en_us&edition=fundamental","pubTime":"2026-07-15 19:47","pubTimestamp":1784116043,"startTime":"0","endTime":"0","summary":"ADM Energy plc ( ($GB:ADME) ) has issued an announcement. ADM Energy PLC has been hit with a winding-up petition from HMRC, filed in the High Court...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/adm-energy-faces-hmrc-winding-up-petition-as-it-scrambles-for-funding?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/adm-energy-faces-hmrc-winding-up-petition-as-it-scrambles-for-funding?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2211817866.USD","BK4189","LU1571399168.USD","BK4597","FTXG","BK4585","BK4588","VEGI","ADME","LU0471298777.SGD","ADM","LU0385154629.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643294463","title":"AstraZeneca’s AZD1390 ADME Study Lays Groundwork for Future Oncology Upside","url":"https://stock-news.laohu8.com/highlight/detail?id=2643294463","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643294463?lang=en_us&edition=fundamental","pubTime":"2026-06-13 00:33","pubTimestamp":1781282039,"startTime":"0","endTime":"0","summary":"AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. AstraZeneca is preparing a new early-stage trial that looks at how i...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/astrazenecas-azd1390-adme-study-lays-groundwork-for-future-oncology-upside?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/astrazenecas-azd1390-adme-study-lays-groundwork-for-future-oncology-upside?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADME"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635781474","title":"InnoCare Announce First Subject Dosed in Phase 1 Clinical Trial of ICP-054, a Novel Potentially Best-in-Class Oral IL-17AA/AF Inhibitor","url":"https://stock-news.laohu8.com/highlight/detail?id=2635781474","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635781474?lang=en_us&edition=fundamental","pubTime":"2026-05-13 19:43","pubTimestamp":1778672580,"startTime":"0","endTime":"0","summary":"- Phase 1 trial designed to evaluate the safety, tolerability, and pharmacokinetic properties of ICP-054 (ZB021) in healthy volunteers- Phase 1 SAD and MAD data expected by year-end 2026 BEIJING, May ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/13/3293904/0/en/InnoCare-Announce-First-Subject-Dosed-in-Phase-1-Clinical-Trial-of-ICP-054-a-Novel-Potentially-Best-in-Class-Oral-IL-17AA-AF-Inhibitor.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADME"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630525317","title":"Erasca Announces Positive Preliminary Phase 1 Dose Escalation Data for Potentially Best-in-Class Pan-RAS Molecular Glue ERAS-0015 in KRAS-Mutant Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2630525317","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630525317?lang=en_us&edition=fundamental","pubTime":"2026-04-28 04:01","pubTimestamp":1777320060,"startTime":"0","endTime":"0","summary":"Robust monotherapy efficacy in KRAS G12X NSCLC: 62% uORR in 2L+ and 75% uORR in post-ICI/platinum 2/3L at 16-32 mg QD PAD, and 64% uORR in 2L+ at 24-32 mg QD RDE Robust monotherapy efficacy in 2L KRAS","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/27/3281996/0/en/Erasca-Announces-Positive-Preliminary-Phase-1-Dose-Escalation-Data-for-Potentially-Best-in-Class-Pan-RAS-Molecular-Glue-ERAS-0015-in-KRAS-Mutant-Solid-Tumors.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DCO","PD","BK4218","LU1169589451.USD","ORR","PK","BK4023","BK4187","CRC","ERAS","IE00B66KJ199.SGD","LU0566484027.USD","BK4181","LU0266512127.USD","CN","ADME","BK4139","IE00B19Z4B17.USD","BK4539","LU1169590202.USD","LU0456854461.SGD","LU1559883803.SGD","BK4213","IE00B7SZL793.SGD","IE0031619046.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630391398","title":"Erasca to Host Conference Call and Webcast to Discuss Preliminary Phase 1 Dose Escalation Data for Potentially Best-in-Class Pan-RAS Molecular Glue ERAS-0015","url":"https://stock-news.laohu8.com/highlight/detail?id=2630391398","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630391398?lang=en_us&edition=fundamental","pubTime":"2026-04-27 20:30","pubTimestamp":1777293000,"startTime":"0","endTime":"0","summary":"Conference call and live webcast today at 4:30 PM Eastern TimeSAN DIEGO, April  27, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/27/3281615/0/en/Erasca-to-Host-Conference-Call-and-Webcast-to-Discuss-Preliminary-Phase-1-Dose-Escalation-Data-for-Potentially-Best-in-Class-Pan-RAS-Molecular-Glue-ERAS-0015.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ERAS","HST","BK4588","PK","BK4139","BK4218","BK4539","ADME","BK4181","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":8,"code":"91000000","status":"200"}]}}